PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY AIMED AT VALIDATING A PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN HIGH-RISK NEUROBLASTOMA PATIENTS

被引：0
|
作者：
Nishimura, Noriyuki [1 ]
Ishida, Toshiaki [2 ]
Yokota, Isao [2 ]
Matsumoto, Kimikazu [2 ]
Shichino, Hiroyuki [2 ]
Kamijo, Takehiko [2 ]
Takimoto, Tetsuya [2 ]
Iehara, Tomoko [2 ]
Tajiri, Tatsuro [2 ]
机构：
[1] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo, Japan
[2] Japan Childrens Canc Grp JCCG Neuroblastoma Comm, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS2-1
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] Characterization of Minimal Residual Disease in Patients with High Risk Neuroblastoma Using DDPCR and RTQ PCR
    Brilliantova, V.
    Druy, A.
    Shevtsov, D.
    Shamanskaya, T.
    Kachanov, D.
    Varfolomeeva, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S320 - S320
  • [22] Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study
    Caballero-Velazquez, Teresa
    Perez-Lopez, Olga
    Yeguas Bermejo, Ana
    Rodriguez Arboli, Eduardo
    Colado Varela, Enrique
    Sempere Talens, Amparo
    Belen Vidriales, Maria
    Sole-Rodriguez, Maria
    Quiros Caso, Covadonga
    Perez Lopez, Estefania
    Reinoso Segura, Marta
    Prats-Martin, Concepcion
    Montesinos, Pau
    Perez-Simon, Jose A.
    CANCERS, 2023, 15 (05)
  • [23] Identification of Patients at High Risk of Cancer after Venous Thromboembolic Disease: A Prospective Multicenter Observational Study
    Pernod, Gilles
    Arnoult, Anne-Cecile
    Genty, Celine
    Galanaud, Jean Philippe
    Colonna, Marc
    Sevestre, Marie Antoinette
    Bosson, Jean Luc
    BLOOD, 2014, 124 (21)
  • [24] Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study
    Metan, Goekhan
    Ciftcioglu, Ayse
    Saba, Rabin
    Kilic, Ayseguel Ulu
    Ozdemir, Kevser
    Cag, Yasemin
    Unal, Demet Kiper
    Aksoy, Firdevs
    Berk, Hande
    Mert, Gurkan
    Tunccan, Ozlem Guzel
    Tombak, Anil
    Balkan, Ilker Inanc
    Cavus, Sema Alp
    Kandemir, Bahar
    Mutlu, Birsen
    Inkaya, Ahmet Cagkan
    Kaynar, Leylagul
    Atay, Memis Hilmi
    Dursun, Fadime Ersoy
    Saydam, Guray
    Unsal, Yakup
    Sari, Simge Fidan
    Akan, Hamdi
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 75 - 88
  • [25] ENectiveness of Preoperative Multidisciplinary Team Discussions for High-Risk Noncardiac Surgical Patients in the Netherlands: A Multicenter Prospective Observational Study
    Vernooij, Jacqueline E.
    Hobrink, Elisha
    van Beest, Paul
    van de Calseijde, Silvie
    Holl, Tanja
    Jansen, Liedewij
    Klinkert, Liane
    Marsman, Marije
    Nouwen, Marinus
    Bettink, Mark Wefers
    Preckel, Benedikt
    Kalkman, Cor J.
    van Leeuwen, Barbara L.
    Festen, Suzanne
    Koning, Nick J.
    ANESTHESIA AND ANALGESIA, 2024, 139 (06): : 2048 - 2050
  • [26] Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma
    van Wezel, Esther M.
    Stutterheim, Janine
    Vree, Florentien
    Zappeij-Kannegieter, Lily
    Decarolis, Boris
    Hero, Barbara
    Berthold, Frank
    Schumacher-Kuckelkorn, Roswitha
    Simon, Thorsten
    Fiocco, Marta
    Voermans, Carlijn
    van Noesel, Max M.
    Caron, Huib N.
    van der Schoot, C. Ellen
    Tytgat, Godelieve A. M.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (08) : 1368 - 1373
  • [27] Addition of anthracyclines as rescue post induction chemotherapy does not allow bone marrow minimal residual disease eradication in patients with high-risk neuroblastoma
    Chambon, F.
    Tchirkov, A.
    Merlin, E.
    Pereira, B.
    Rochette, E.
    Ducassou, S.
    Piguet, C.
    Gandemer, V.
    Schneider, P.
    Rubie, H.
    Kanold, J.
    REVUE D ONCOLOGIE HEMATOLOGIE PEDIATRIQUE, 2014, 2 (03): : 150 - 153
  • [28] Minimal Residual Disease in Bone Marrow of Patients with High Risk Neuroblastoma in 31 Patients from a Single Institution in Argentina
    Cimolai, M.
    Medina, A.
    Mitchell, R.
    Rubio, P.
    Rossi, J.
    Zubizarreta, P.
    Cacciavillano, W.
    Alonso, C.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S225 - S226
  • [29] The application and value of radiotherapy at the primary site in patients with high-risk neuroblastoma
    Wei, Zixuan
    Li, Jie
    Jin, Yan
    Liu, Yun
    Wang, Peiguo
    Cao, Yanna
    Zhao, Qiang
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1134):
  • [30] Prospective study on the prognostic impact of minimal residual disease in bone marrow of breast cancer patients.
    Funke, IM
    Untch, M
    Mayer, B
    Schraut, W
    Schildberg, FW
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S62 - S62
12345